Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fernandes

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Neotropical Entomology|October 27, 2015
Leaf Fluctuating Asymmetry and Herbivory of Tibouchina heteromalla in Restored and Natural EnvironmentsG W Fernandes, S C S De Oliveira, I R Campos, et al.
Future Oncology (London, England)|October 18, 2019
Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancerJohn Fp Bridges, Marie de la Cruz, Melissa Pavilack, et al.
Clinical Kidney Journal|November 12, 2024
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety studyThomas Jaeger, Emanuel Lohrmann, Adachukwu Ezenekwe, et al.
Future Oncology (London, England)|May 1, 2019
Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancerKellie J Ryan, Karen E Skinner, Ancilla W Fernandes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 7, 2025
Treatment Response Rates and Kidney Outcomes among Adults with Primary FSGSJohn J Sim, Mercedes A Munis, Benjamin Lewing, et al.
BMC Cancer|April 30, 2020
EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitorsAnne C Chiang, Ancilla W Fernandes, Melissa Pavilack, et al.
BMC Nephrology|May 19, 2025
Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature reviewSarah N Ali, Nicole Fusco, Dilip Makhija, et al.
Medical Oncology (Northwood, London, England)|February 2, 2019
Real-world outcomes in patients with unresected stage III non-small cell lung cancerKellie J Ryan, Karen E Skinner, Ancilla W Fernandes, et al.
Journal of the Endocrine Society|October 30, 2020
Temporal Pole Responds to Subtle Changes in Local Thyroid Hormone SignalingCícera P Marcelino, Elizabeth A McAninch, Gustavo W Fernandes, et al.
Endocrine Reviews|April 30, 2019
Paradigms of Dynamic Control of Thyroid Hormone SignalingAntonio C Bianco, Alexandra Dumitrescu, Balázs Gereben, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Neotropical Entomology|October 27, 2015
Leaf Fluctuating Asymmetry and Herbivory of Tibouchina heteromalla in Restored and Natural EnvironmentsG W Fernandes, S C S De Oliveira, I R Campos, et al.
Future Oncology (London, England)|October 18, 2019
Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancerJohn Fp Bridges, Marie de la Cruz, Melissa Pavilack, et al.
Clinical Kidney Journal|November 12, 2024
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety studyThomas Jaeger, Emanuel Lohrmann, Adachukwu Ezenekwe, et al.
Future Oncology (London, England)|May 1, 2019
Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancerKellie J Ryan, Karen E Skinner, Ancilla W Fernandes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 7, 2025
Treatment Response Rates and Kidney Outcomes among Adults with Primary FSGSJohn J Sim, Mercedes A Munis, Benjamin Lewing, et al.
BMC Cancer|April 30, 2020
EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitorsAnne C Chiang, Ancilla W Fernandes, Melissa Pavilack, et al.
BMC Nephrology|May 19, 2025
Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature reviewSarah N Ali, Nicole Fusco, Dilip Makhija, et al.
Medical Oncology (Northwood, London, England)|February 2, 2019
Real-world outcomes in patients with unresected stage III non-small cell lung cancerKellie J Ryan, Karen E Skinner, Ancilla W Fernandes, et al.
Journal of the Endocrine Society|October 30, 2020
Temporal Pole Responds to Subtle Changes in Local Thyroid Hormone SignalingCícera P Marcelino, Elizabeth A McAninch, Gustavo W Fernandes, et al.
Endocrine Reviews|April 30, 2019
Paradigms of Dynamic Control of Thyroid Hormone SignalingAntonio C Bianco, Alexandra Dumitrescu, Balázs Gereben, et al.
Pageof 14